Hills et al. v. BioXcel Therapeutics, Inc., et al.
Did you purchase BioXcel Therapeutics, Inc. (BTAI) stock?
Law Firm: Levi & Korsinsky, LLP
Est. Recovery
$9,750,000
About this case
Pursuant to Federal Rule of Civil Procedure 23 and a District of Connecticut order, court-appointed class representatives Tonya Hills and the Oklahoma Law Enforcement Retirement System reached a proposed $9,750,000 cash settlement with BioXcel Therapeutics, Inc. and defendants Vimal Mehta, Richard Steinhart, and Robert Risinger. If approved, the settlement will resolve all claims alleging misleading statements about BioXcel common stock (CUSIP 09075P204) purchased March 9–June 28, 2023. Estimated recovery is about $1.52 per share before court-approved fees and expenses, varying by purchase and sale dates. Class representatives cite the guaranteed cash benefit and avoidance of litigation risk; defendants cite eliminating continued expense and uncertainty.
Do you qualify?
Join this case via Levi & Korsinsky, LLPs intake form.